Skip to main content
Erschienen in: Tumor Biology 2/2014

01.02.2014 | Research Article

Antiapoptotic gene BAG-1 vector structure of RNA interference and endogenous targeted screening in colon cancer cell lines

verfasst von: Nian-feng Sun, Ai-ling Tian, Zhan-ao Liu, San-yuan Hu, An-bin Hu

Erschienen in: Tumor Biology | Ausgabe 2/2014

Einloggen, um Zugang zu erhalten

Abstract

The purposes of the present work were to construct the shRNA plasmids for BAG-1 gene of human and test the expression of mRNA and protein of BAG-1. Recombinant plasmids containing green fluorescent protein reporter genes are constructed using gene cloning methods. The shRNA plasmids for the BAG-1 gene are constructed by RNA interference technology. We applied fluorescent plasmid-transfected target cells in the cell transfection experiments and monitored the transfection rate of plasmids by observing the fluorescence amount. We transfected three synthesized shRNA in target screening cell and adopted RT-PCR and Western test to identify the difference of target gene transfection and translation level in cells. The specific shRNA plasmid for the BAG-1 gene was successfully recombined, and stably transfected colon cancer Lo Vo cell lines were obtained. The results present that the constructed shRNA plasmids significantly inhibited the expression of mRNA and protein of Lo Vo cell BAG-1, and can maintain the effect for a long term. pGPH1/GFP/Neo-BAG-1-homo-825 was screened as the optimum sequence of interference so as to lay a solid foundation to explore into the research on the BAG-1 gene and the biological behavior of colon cancer cells. It showed the remarkable advantage of RNAi in the generation of posttranscriptional gene silencing.
Literatur
1.
Zurück zum Zitat Lindgren M, Rosenthal-Aizman K, Saar K. Overcoming methotrexate resistance in breast cancer tumour cells by the use of a new cell-penetrating peptide. Biochem Pharmacol. 2006;71:416–25.PubMedCrossRef Lindgren M, Rosenthal-Aizman K, Saar K. Overcoming methotrexate resistance in breast cancer tumour cells by the use of a new cell-penetrating peptide. Biochem Pharmacol. 2006;71:416–25.PubMedCrossRef
2.
Zurück zum Zitat Ortiz R, Melguizo C, Prados J, Alvarez PJ, Caba O, Rodriguez-Serrano F, et al. New gene therapy strategies for cancer treatment: a review of recent patents. Recent Patents on Anti-Cancer Drug Discovery. 2012;7:297–312. Ortiz R, Melguizo C, Prados J, Alvarez PJ, Caba O, Rodriguez-Serrano F, et al. New gene therapy strategies for cancer treatment: a review of recent patents. Recent Patents on Anti-Cancer Drug Discovery. 2012;7:297–312.
3.
Zurück zum Zitat Leinonen HM, Ruotsalainen A-K, Määttä A-M, Laitinen HM, Kuosmanen SM. Oxidative stress-regulated lentiviral TK/GCV gene therapy for lung cancer treatment. Cancer Research. 2012;72:6227–35.PubMedCrossRef Leinonen HM, Ruotsalainen A-K, Määttä A-M, Laitinen HM, Kuosmanen SM. Oxidative stress-regulated lentiviral TK/GCV gene therapy for lung cancer treatment. Cancer Research. 2012;72:6227–35.PubMedCrossRef
4.
Zurück zum Zitat Van Laar RK. An online gene expression assay for determining adjuvant therapy eligibility in patients with stage 2 or 3 colon cancer. British Journal of Cancer. 2010;103:1852–7.PubMedCentralPubMedCrossRef Van Laar RK. An online gene expression assay for determining adjuvant therapy eligibility in patients with stage 2 or 3 colon cancer. British Journal of Cancer. 2010;103:1852–7.PubMedCentralPubMedCrossRef
5.
Zurück zum Zitat de Gramont A, de Gramont A, Chibaudel B, Bachet J-B, Larsen AK, Tournigand C, et al. From chemotherapy to targeted therapy in adjuvant treatment for stage III colon cancer. Seminars in Oncology. 2011;38:521–32. de Gramont A, de Gramont A, Chibaudel B, Bachet J-B, Larsen AK, Tournigand C, et al. From chemotherapy to targeted therapy in adjuvant treatment for stage III colon cancer. Seminars in Oncology. 2011;38:521–32.
6.
Zurück zum Zitat Dykxhoom DM, Liebennan J. The silent revolution: RNA interference as basic biology, research tool, and therapeutic. Annu Rev Med. 2005;56:401–23.CrossRef Dykxhoom DM, Liebennan J. The silent revolution: RNA interference as basic biology, research tool, and therapeutic. Annu Rev Med. 2005;56:401–23.CrossRef
7.
Zurück zum Zitat Hua T, editor. The theory and apply of RNA interference. 1st ed. Beijing: Beijing Science and Technology Press; 2006. Hua T, editor. The theory and apply of RNA interference. 1st ed. Beijing: Beijing Science and Technology Press; 2006.
9.
Zurück zum Zitat Maryla K, Bruce CT, Ahmed S, Stan K, John CR. Expression of BAG-1 protein correlates with aggressive behavior of prostate cancers. Prostate. 2006;66:801–10.CrossRef Maryla K, Bruce CT, Ahmed S, Stan K, John CR. Expression of BAG-1 protein correlates with aggressive behavior of prostate cancers. Prostate. 2006;66:801–10.CrossRef
10.
Zurück zum Zitat Guo-bin W, Nian-feng S, Qing-xian H. Expression of the anti-apoptotic gene Bag-1 and Bcl-2 in the colorectal cancer and there interaction. Chin Eep Surg. 2005;22:227–8. Guo-bin W, Nian-feng S, Qing-xian H. Expression of the anti-apoptotic gene Bag-1 and Bcl-2 in the colorectal cancer and there interaction. Chin Eep Surg. 2005;22:227–8.
11.
Zurück zum Zitat Nian-feng S, Jing-bo C, Guo-bin W. Expression and relation of the anti-apoptotic gene Bag-1 and Bcl-2 in the colon cancer. China Journal of Modern Medicine. 2007;17:769–72. Nian-feng S, Jing-bo C, Guo-bin W. Expression and relation of the anti-apoptotic gene Bag-1 and Bcl-2 in the colon cancer. China Journal of Modern Medicine. 2007;17:769–72.
12.
Zurück zum Zitat Nian-feng S, Qing-yi M, Ai-ling T. Expressions of the anti-apoptotic genes Bag-1 and Bcl-2 in colon cancer and their relationship. The American Journal of Surgery. 2010;200:341–5.CrossRef Nian-feng S, Qing-yi M, Ai-ling T. Expressions of the anti-apoptotic genes Bag-1 and Bcl-2 in colon cancer and their relationship. The American Journal of Surgery. 2010;200:341–5.CrossRef
14.
Zurück zum Zitat Yang JY, Cai ZQ, Du W, Li JC, Chen TX, Xu YH. The relationship between Bag-1 and gastric cancer clinicopathologic characteristic. The Chinese-German Journal of Clinical Oncology. 2011;10:459–61.CrossRef Yang JY, Cai ZQ, Du W, Li JC, Chen TX, Xu YH. The relationship between Bag-1 and gastric cancer clinicopathologic characteristic. The Chinese-German Journal of Clinical Oncology. 2011;10:459–61.CrossRef
15.
Zurück zum Zitat Hassumi-Fukasawa MK, Miranda-Camargo FA, Zanetti BR, Galano DF, Ribeiro-Silva A, Soares EG. Expression of BAG-1 and PARP-1 in precursor lesions and invasive cervical cancer associated with human papillomavirus (HPV). Pathology & Oncology Research. 2012;18:929–37.CrossRef Hassumi-Fukasawa MK, Miranda-Camargo FA, Zanetti BR, Galano DF, Ribeiro-Silva A, Soares EG. Expression of BAG-1 and PARP-1 in precursor lesions and invasive cervical cancer associated with human papillomavirus (HPV). Pathology & Oncology Research. 2012;18:929–37.CrossRef
16.
Zurück zum Zitat Clemo NK, Collard TJ, Southem SL. BAG-l is up-regulated in colorectal turnout progression and promotes colorectal tumour cell survival through increased NF-kappaB activity. Carcinogenesis. 2008;29:849–57.PubMedCrossRef Clemo NK, Collard TJ, Southem SL. BAG-l is up-regulated in colorectal turnout progression and promotes colorectal tumour cell survival through increased NF-kappaB activity. Carcinogenesis. 2008;29:849–57.PubMedCrossRef
Metadaten
Titel
Antiapoptotic gene BAG-1 vector structure of RNA interference and endogenous targeted screening in colon cancer cell lines
verfasst von
Nian-feng Sun
Ai-ling Tian
Zhan-ao Liu
San-yuan Hu
An-bin Hu
Publikationsdatum
01.02.2014
Verlag
Springer Netherlands
Erschienen in
Tumor Biology / Ausgabe 2/2014
Print ISSN: 1010-4283
Elektronische ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-013-1140-1

Weitere Artikel der Ausgabe 2/2014

Tumor Biology 2/2014 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.